However, it is also important to note that oxytocin is a partial agonist of the μ-opioid receptor [124] and regulator of the κ-opioid receptor [125], with the opioidergic system an important determinant of immune regulation across diverse medical conditions [126], including in the tumor microenvironment [127]. The gene discussed is OXT; the disease is neoplasm.